Skip to main content
Premium Trial:

Request an Annual Quote

Genset Adds Pernet to Board

Premium

Ž

Genset in Paris has elected Andre Pernet to its board of directors. Pernet’s career includes 26 years at Abbott Laboratories, from which he retired in February 1999 as corporate officer and vice-president, pharmaceutical products research and development. At that post, he led an organization of 2,700 scientists with an annual budget responsibility of $600 million.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.